Clinical Trial Detail

NCT ID NCT02045446
Title Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab + Erlotinib

Docetaxel + Gemcitabine

Age Groups: adult

No variant requirements are available.